Afrigen and Univercells partner to develop African-owned Covid-19 vaccine
Under the deal, an mRNA vaccine that is thermostable at refrigerator temperatures will be produced.

Under the deal, an mRNA vaccine that is thermostable at refrigerator temperatures will be produced.
Aspen will manufacture the Covid-19 vaccines using drug substances supplied by J&J.
The company intends to make an investment of up to $500m in the manufacturing facility in Kenya.
Through the deal extension, ER-Kim gained exclusive rights to commercialise QRX003 in six additional countries.
In the initial stage, Novavax will supply five million doses of the protein-based Covid-19 vaccine to Israel.
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
ByWe've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
ByOn SAHPRA granting EUA for the vaccine, SII will produce and market it in the region under the brand name…
Thank you for subscribing to Pharmaceutical Technology